Table 1 Inclusion and exclusion criteria for this scoping review
Criteria | Inclusion | Exclusion |
|---|---|---|
Population | Human | Animal, plants |
| Â | Adult | Children and neonates |
| Â | Intensive care units | Other hospital wards |
| Â | ICU infections, especially those acquired during ICU stay | Â |
| Â | Laboratory results of screening for the presence of multidrug-resistant bacteria, especially ESKAPE species among ICU patients, healthcare workers, or the ICU environment | Â |
| Â | Lower-middle income countries | Â |
Intervention | Preventive measures to limit nosocomial acquisition and infection of bacterial pathogens | Â |
Comparator | Not Applicable | Â |
Outcomes | Infection and/or acquisition | Â |
| Â | Identification and susceptibility pattern of targeted pathogens (ESKAPE species) | Â |
| Â | Compliance with prevention protocols (e.g. hand hygiene) | Â |
| Â | Mortality | Â |
| Â | Length of stay | Â |
Language | English Language | Â |
Study design | Case control study | Editorials |
| Â | Cohort studies | Case series reports |
| Â | Cross-sectional studies | Conference abstracts/reports |
| Â | Longitudinal studies | Reviews |
| Â | Modelling studies | Â |
| Â | Laboratory-based studies | Â |
Quality of journal | Q1 or Q2 based on rank on Web of Science | Q3 or Q4, or not ranked in Web of Science |